Total Payments
$5,704
2024 Payments
$1,047
Companies
38
Transactions
346
Medicare Patients
1,410
Medicare Billing
$134,721
Payment Breakdown by Category
Food & Beverage$5,654 (99.1%)
Education$49.81 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,654 | 341 | 99.1% |
| Education | $49.81 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $778.06 | 44 | $0 (2024) |
| ABBVIE INC. | $744.44 | 43 | $0 (2024) |
| Novo Nordisk Inc | $651.72 | 34 | $0 (2024) |
| PFIZER INC. | $508.71 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $463.01 | 50 | $0 (2024) |
| Amgen Inc. | $288.51 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $240.51 | 14 | $0 (2024) |
| Lilly USA, LLC | $217.08 | 14 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $191.54 | 11 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $132.10 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,047 | 55 | ABBVIE INC. ($268.24) |
| 2023 | $1,033 | 60 | ABBVIE INC. ($219.31) |
| 2022 | $1,034 | 53 | Novo Nordisk Inc ($194.63) |
| 2021 | $417.50 | 20 | AstraZeneca Pharmaceuticals LP ($59.71) |
| 2020 | $156.38 | 10 | AstraZeneca Pharmaceuticals LP ($80.77) |
| 2019 | $601.11 | 38 | GlaxoSmithKline, LLC. ($127.08) |
| 2018 | $650.60 | 52 | GlaxoSmithKline, LLC. ($129.17) |
| 2017 | $764.54 | 58 | GlaxoSmithKline, LLC. ($111.88) |
All Payment Transactions
346 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.50 | General |
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Oncology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PAIN | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: PAIN | ||||||
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/30/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: PAIN | ||||||
| 07/31/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 369 | 432 | $68,930 | $35,489 |
| 2022 | 12 | 390 | 451 | $63,200 | $36,134 |
| 2021 | 10 | 334 | 381 | $58,800 | $33,817 |
| 2020 | 9 | 317 | 393 | $61,245 | $29,280 |
Total Patients
1,410
Total Services
1,657
Medicare Billing
$134,721
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 129 | $24,485 | $12,217 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $16,170 | $9,452 | 58.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 50 | 66 | $9,215 | $4,074 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $6,345 | $3,125 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 41 | $5,740 | $2,664 | 46.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 24 | 25 | $4,750 | $2,527 | 53.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $630.00 | $617.40 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 19 | $570.00 | $558.60 | 98.0% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 14 | 14 | $1,025 | $254.54 | 24.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $0.21 | $0.21 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 82 | 82 | $16,410 | $11,089 | 67.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 119 | $19,860 | $10,696 | 53.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 39 | $9,825 | $4,979 | 50.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 44 | 60 | $7,050 | $4,109 | 58.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 35 | $4,225 | $2,320 | 54.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 16 | $2,665 | $1,434 | 53.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 24 | $720.00 | $708.60 | 98.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $330.00 | $326.10 | 98.8% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 20 | 20 | $1,175 | $257.60 | 21.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $800.00 | $153.50 | 19.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 14 | 14 | $140.00 | $60.80 | 43.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 15 | 15 | $0.15 | $0.15 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 79 | 79 | $15,405 | $10,991 | 71.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 52 | 61 | $15,250 | $7,048 | 46.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 72 | $11,880 | $6,812 | 57.3% |
About Dr. Pierre Manzo, MD
Dr. Pierre Manzo, MD is a Family Medicine healthcare provider based in East Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033199468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pierre Manzo, MD has received a total of $5,704 in payments from pharmaceutical and medical device companies, with $1,047 received in 2024. These payments were reported across 346 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,654).
As a Medicare-enrolled provider, Manzo has provided services to 1,410 Medicare beneficiaries, totaling 1,657 services with total Medicare billing of $134,721. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location East Greenwich, RI
- Active Since 01/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033199468
Products in Payments
- FARXIGA (Drug) $375.45
- UBRELVY (Drug) $364.47
- Ozempic (Drug) $326.92
- NURTEC ODT (Drug) $311.42
- Rybelsus (Drug) $259.12
- VRAYLAR (Drug) $183.63
- PREVNAR 20 (Biological) $126.44
- TRELEGY ELLIPTA (Drug) $124.20
- EVENITY (Biological) $121.45
- QULIPTA (Drug) $119.17
- BREZTRI (Drug) $109.94
- Cologuard Collection Kit (Device) $98.71
- BEXSERO (Biological) $98.22
- Otezla (Drug) $95.55
- TRULICITY (Drug) $90.26
- UTIBRON (Drug) $89.68
- NEXTSTELLIS (Drug) $88.44
- BENLYSTA (Biological) $86.08
- FASENRA (Drug) $82.33
- ORENCIA (Biological) $77.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in East Greenwich
Dr. Chad Lamendola, M.d, M.D
Family Medicine — Payments: $4,957
Family Medicine $4,957
Dr. Ellen Hight, Md, MD
Family Medicine — Payments: $4,757
Family Medicine $4,757
Dr. John Slattery, Md, MD
Family Medicine — Payments: $3,341
Family Medicine $3,341
Thomas Green, Do, DO
Family Medicine — Payments: $2,474
Family Medicine $2,474
Lauren Goddard, M.d, M.D
Family Medicine — Payments: $559.96
Family Medicine $559.96
Dr. Karen Blackmer, Md, MD
Family Medicine — Payments: $437.03
Family Medicine $437.03